Greater Than Sevenfold Return on Investment for a Comprehensive Patient Blood Management Program With Equivalent or Improved Outcomes.

Frank, Steven M; Hensley, Nadia B; Thomas, Ananda J; Dawson, Clarita G; Resar, Linda M S; Ulatowski, John A; Crowe, Elizabeth P

Frank, Steven M; Hensley, Nadia B; Thomas, Ananda J; Dawson, Clarita G; Resar, Linda M S; Ulatowski, John A; Crowe, Elizabeth P.

Afiliação

Frank SM; From the Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
Hensley NB; From the Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
Thomas AJ; From the Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
Dawson CG; From the Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
Resar LMS; Department of Medicine (Hematology), Oncology, Pathology, Center for Bloodless Medicine and Surgery, Institute for Cellular Engineering, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
Ulatowski JA; Department of Pathology (Transfusion Medicine), The Johns Hopkins Medical Institutions, Baltimore, Maryland.
Crowe EP; Department of Pathology (Transfusion Medicine), The Johns Hopkins Medical Institutions, Baltimore, Maryland.

Anesth Analg ; 138(6): 1345-1348, 2024 Jun 01.

Article em En | MEDLINE | ID: mdl-38530909

Assuntos

Transfusão de Sangue; Análise Custo-Benefício; Humanos; Transfusão de Sangue/economia; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transfusão de Sangue / Análise Custo-Benefício Limite: Humans Idioma: En Revista: Anesth Analg Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google